CASSETTA, MARIA IRIS
 Distribuzione geografica
Continente #
NA - Nord America 1.089
EU - Europa 920
AS - Asia 179
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.193
Nazione #
US - Stati Uniti d'America 1.087
PL - Polonia 392
RU - Federazione Russa 281
IE - Irlanda 80
IT - Italia 71
CN - Cina 50
HK - Hong Kong 47
SE - Svezia 45
SG - Singapore 30
JO - Giordania 22
GB - Regno Unito 13
VN - Vietnam 12
FI - Finlandia 11
DE - Germania 10
IN - India 8
BE - Belgio 7
TR - Turchia 5
UA - Ucraina 5
CI - Costa d'Avorio 3
PK - Pakistan 3
AM - Armenia 2
CA - Canada 2
ES - Italia 2
CH - Svizzera 1
EG - Egitto 1
EU - Europa 1
FR - Francia 1
LV - Lettonia 1
Totale 2.193
Città #
Warsaw 392
Santa Clara 156
Fairfield 149
Chandler 106
Ashburn 82
Dublin 77
Seattle 77
Wilmington 59
Woodbridge 58
Cambridge 56
Ann Arbor 47
Houston 43
Hong Kong 30
Altamura 26
Beijing 25
Lawrence 25
Florence 23
Singapore 20
Princeton 18
Buffalo 17
Boston 14
Shanghai 13
Dong Ket 10
San Diego 9
Brussels 7
Mumbai 7
Jacksonville 6
Falls Church 5
Izmir 5
Medford 5
Boardman 4
Moscow 4
Abidjan 3
Fiesole 3
Multan 3
Phoenix 3
Yubileyny 3
Barcelona 2
Bari 2
Clifton 2
Hounslow 2
London 2
Los Angeles 2
New York 2
Norwalk 2
Sesto Fiorentino 2
Toronto 2
West Jordan 2
Yerevan 2
Andover 1
Bern 1
Bologna 1
Bremen 1
Foggia 1
Hangzhou 1
Helsinki 1
Hillsboro 1
Kent 1
Leawood 1
Ludwigshafen am Rhein 1
Nanning 1
Philadelphia 1
Pune 1
Ramsis 1
Redwood City 1
Riga 1
San Francisco 1
San Mateo 1
Totale 1.633
Nome #
Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia. 261
Breakthrough bacteremia by linezolid-susceptible Enterococcus faecalis under linezolid treatment in a severe polytrauma patient. 240
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer. 219
Linezolid extracorporeal removal during haemodialysis with high cut-off membrane in critically ill patients 170
Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? 142
Auranofin and its Analogues Show Potent Antimicrobial Activity Covering Multiresistant Pathogens: Structure-Activity Relationships 140
Management of Meningitis Caused by Multi Drug-Resistant Acinetobacter Baumannii: Clinical, Microbiological and Pharmacokinetic Results in a Patient Treated with Colistin Methanesulfonate. 126
Daptomycin serum levels in critical patients undergoing continuous renal replacement 120
Ceftolozane-tazobactam pharmacokinetics during extracorporeal membrane oxygenation in a lung transplant recipient 117
Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections 105
Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration? 98
Fluorochinoloni. 84
Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis 77
Administering gemcitabine as fixed-dose-rate infusion in combination with cisplatin, potentially effective target plasma concentrations are achieved in patients with advanced non-small cell lung cancer 71
Plasma and intracellular pharmacokinetic (PK) study of prolonged infusion (PI) of gemcitabine (G) in combination with bolus cisplatin (C), in advanced nonsmall cell lung cancer: Preliminary results 68
FLUOROCHINOLONI 56
Pharmacokinetics and blister fluid penetration of ticarcillin/clavulanate in adults 50
Chemioterapici Antimicrobici – Fluorochinoloni 48
Clinical pharmacokinetics of cefpodoxime proxetil in older patients 37
Totale 2.229
Categoria #
all - tutte 5.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020309 0 0 0 0 51 47 43 47 40 39 35 7
2020/2021263 25 26 11 25 11 18 12 17 21 66 13 18
2021/2022154 3 13 16 1 17 8 5 10 8 5 32 36
2022/2023368 28 85 24 19 25 67 45 17 44 4 7 3
2023/2024129 6 9 24 4 13 19 7 32 2 5 2 6
2024/2025531 32 105 60 147 187 0 0 0 0 0 0 0
Totale 2.229